Simulations Plus Inc
NASDAQ:SLP

Watchlist Manager
Simulations Plus Inc Logo
Simulations Plus Inc
NASDAQ:SLP
Watchlist
Price: 20.91 USD 0.67% Market Closed
Market Cap: $421.1m

Operating Margin

-88.3%
Current
Declining
by 91.6%
vs 3-y average of 3.2%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-88.3%
=
Operating Income
$-69.5m
/
Revenue
$78.7m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-88.3%
=
Operating Income
$-69.5m
/
Revenue
$78.7m

Peer Comparison

Country Company Market Cap Operating
Margin
US
Simulations Plus Inc
NASDAQ:SLP
421.3m USD
Loading...
US
Veeva Systems Inc
NYSE:VEEV
36.5B USD
Loading...
US
Cerner Corp
LSE:0R00
31.3B USD
Loading...
AU
Pro Medicus Ltd
ASX:PME
18.9B AUD
Loading...
JP
M3 Inc
TSE:2413
1.4T JPY
Loading...
US
Doximity Inc
NYSE:DOCS
7.6B USD
Loading...
US
Waystar Holding Corp
NASDAQ:WAY
5.2B USD
Loading...
SE
Sectra AB
STO:SECT B
43.2B SEK
Loading...
CN
Winning Health Technology Group Co Ltd
SZSE:300253
26.7B CNY
Loading...
IN
Inventurus Knowledge Solutions Ltd
NSE:IKS
283.3B INR
Loading...
US
Heartflow Inc
NASDAQ:HTFL
2.8B USD
Loading...

Market Distribution

Lower than 85% of companies in the United States of America
Percentile
15th
Based on 14 112 companies
15th percentile
-88.3%
Low
-4 087 900% — -5.1%
Typical Range
-5.1% — 14.8%
High
14.8% — 1 032 600%
Distribution Statistics
the United States of America
Min -4 087 900%
30th Percentile -5.1%
Median 6%
70th Percentile 14.8%
Max 1 032 600%

Simulations Plus Inc
Glance View

Market Cap
421.1m USD
Industry
Health Care

Simulations Plus, Inc. provides modeling and simulation software and consulting services supporting drug discovery, development research and regulatory submissions. The company is headquartered in Lancaster, California and currently employs 135 full-time employees. The company provides prediction of properties of molecules utilizing artificial-intelligence- and machine-learning-based technology. The company also provides consulting services ranging from early drug discovery through preclinical and clinical trial development to regulatory submissions in support of product approval. The company offers 11 software products for pharmaceutical research and development, which includes GastroPlus, DDDPlus, MembranePlus, DILIsym, NAFLDsym, ADMET Predictor, MedChem Designer, MedChem Studio, PKPlus, KIWI and Monolix Suite of products through Lixoft. Its software and consulting services are provided to pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies and to academic and regulatory agencies worldwide for use in the conduct of industry-based research. Cognigen Corporation, DILIsym Services, Inc. and Lixoft are its subsidiaries.

SLP Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-88.3%
=
Operating Income
$-69.5m
/
Revenue
$78.7m
What is Simulations Plus Inc's current Operating Margin?

The current Operating Margin for Simulations Plus Inc is -88.3%, which is below its 3-year median of 3.2%.

How has Operating Margin changed over time?

Over the last 3 years, Simulations Plus Inc’s Operating Margin has decreased from 22.5% to -88.3%. During this period, it reached a low of -88.3% on Dec 30, 2025 and a high of 22.5% on Oct 30, 2022.

Back to Top